10,11,12,13-TETRAHYDRODESMYCOSIN-DIETHYLACETAL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 7WbXxl0BemM |
|---|---|
| InChI | InChI=1S/C43H79NO15/c1-13-32-29(22-55-43-41(52-12)40(51-11)37(49)27(8)57-43)18-23(4)16-17-30(45)24(5)19-28(20-34(53-14-2)54-15-3)39(25(6)31(46)21-33(47)58-32)59-42-38(50)35(44(9)10)36(48)26(7)56-42/h23-29,31-32,34-43,46,48-50H,13-22H2,1-12H3/t23?,24?,25?,26-,27+,28?,29?,31?,32?,35+,36-,37+,38+,39?,40+,41+,42-,43+/m0/s1 |
| InChIKey | ZZUSBNPJGLDDSA-GNBHLITNSA-N |
| Mol Weight | 850.1 g/mol |
| Molecular Formula | C43H79NO15 |
| Exact Mass | 849.544971 g/mol |
| Enantiomer InChIKey | ZZUSBNPJGLDDSA-IXJPMWIVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
4'-DEOXY-10,11,12,13-TETRAHYDRODESMYCOSIN
6108-C
Mycinamicin V
GERI-155
CHALCOMYCIN-A
1-O-(3,4-DIHYDROXYPHENYL)-ETHYL-BETA-D-APIFURANOSYL-(1->2)-ALPHA-L-RHAMNOPYRANOSYL-(1->3)-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE;LUTEOSIDE_C
NEWBOULDIOSIDE;2-(3,4-DIHYDROXYPHENYL)-ETHYL-O-BETA-D-APIOFURANOSYL-(1->2)-O-ALPHA-L-RHAMNOPYRANOSYL-(1->3)-6-O-E-FERULOYL-BETA-D-GLUCOPYRANOSIDE
5-(METHOXYCARBONYL)-PENTYL-ALPHA-L-FUCOPYRANOSYL-(1->2)-4-O-METHYL-BETA-D-GALACTOPYRANOSYL-(1->3)-2-ACETAMIDE-2-DEOXY-ALPHA-D-GALACTOPYRANOSIDE
MARKHAMIOSIDE-B;3-HYDROXY-4-METHOXY-BETA-PHENYLETHOXY-O-[BETA-APIOFURANOSYL-(1''''->2'')-ALPHA-RHAMNOPYRANOSYL-(1'''->3'')-6''-O-FERULOYL-BETA-GLUCOPYRAN
2'-O-ACETYLPOLIUMOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| 10,11,12,13-Tetrahydro Derivatives of Tylosin. II. Synthesis, Antibacterial Activity and Tissue Distribution of 4'-Deoxy-10,11,12,13-tetrahydrodesmycosin. | The Journal of Antibiotics | 1995 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.